A new case of dementia arises every 3 seconds, and by the year 2050, projections indicate that 139 million people will be living with Alzheimer's or related conditions. While traditional pharmaceutical processes often require billions of dollars and take 10-15 years to complete drug development, our approach offers a stark contrast. The @Neuron_Percepta trial demonstrates the capacity of DeSci to operate independently of market forces while delivering significant, tangible results. Within a matter of months, we successfully raised $500K with the support of 115 individuals. We have since obtained IRB approval and initiated trials that monitor both biomarkers and cognitive performance. Our team remains dedicated to advancing solutions for diseases that impact millions of lives.